Kit ELISA sandwich Fractalkine-Cell Lysate (CX3CL1) (rat): quantitative assay of Rt Fractalkine in cell and tissue lysates. The test recognizes only the natural and recombinant forms of Rt Fractalkine.
Accession number
O55145
Dose range
2.74-2000 pg/ml
Sensitivity of the dosage
5 pg/ml
Calibration range
5 pg/ml to 2000 pg/ml
Dose
ELISA solid-phase sandwich
Brand
Invitrogen
Kit ELISA sandwich Fractalkine-Cell Lysate (CX3CL1) (rat): quantitative assay of Rt Fractalkine in cell and tissue lysates. The test recognizes only the natural and recombinant forms of Rt Fractalkine.
Kit ELISA sandwich Fractalkine-Cell Lysate (CX3CL1) (rat): quantitative assay of Rt Fractalkine in cell and tissue lysates. The test recognizes only the natural and recombinant forms of Rt Fractalkine.
Method principle: This ELISA solid phase sandwich test (immuno-enzymatic dose) measures the amount of target bound between a pair of matched antibodies. A specific target antibody is pre-adsorbed into the wells of the supplied microplate. Samples, standards or controls are added to these wells and bind to immobilized antibodies (capture antibodies). The sandwich is formed by adding the second antibody (detection antibody), then a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this signal is directly proportional to the concentration of the target present in the original sample.
Rigorous validation: Each batch manufactured from this ELISA kit is checked for criteria such as sensitivity, specificity, accuracy and reproducibility from one batch to another (see the package leaflet for more information on validation).
Chemokines are a family of proteins associated with leukocyte trafficking in immune monitoring and recruitment of inflammatory cells. They are classified according to the position of the main cysteine residues. CX3CL1 is a CX3C chemokine known to induce adhesion and migration of leukocytes mediated by a soluble form and bound to the membrane, respectively. Recent experiments have shown that CX3CL1 can suppress the production of nitrous oxide, d的interleukin-6, and TNF-a in activated microgelian and neuronal cells, suggesting that it can act as an intrinsic inhibitor against neurotoxicity by activated microglia. Its receptor, CX3CR1, also functions as a co-receptor for the fusion of VIH-1 and VIH-2 envelopes and viral infection, which can be inhibited by CX3CL1.